Market Place
Sourcing Support
AstraZeneca completes acquisition of Gracell
22 Feb 2024 //
INDIAN PHARMA POST
Gracell Biotechnologies Announces Shareholders™ Approval of Merger Agreement
20 Feb 2024 //
GLOBENEWSWIRE
Gracell Announces FDA Clearance of IND Application for Ph 1 of FasTCAR-T GC012F
29 Jan 2024 //
GLOBENEWSWIRE
AstraZeneca to buy China`s Gracell Biotechnologies in $1.2 bln deal
27 Dec 2023 //
PRESS RELEASE
Gracell Announces NMPA Clearance for IND for Ph 1/2 Trial of FasTCAR-T GC012F
21 Dec 2023 //
GLOBENEWSWIRE
Biotech CAR-T roundup: Autolus, Gracell tout early-stage data at #ASH23
12 Dec 2023 //
ENDPTS
Gracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F
11 Dec 2023 //
GLOBENEWSWIRE
Gracell Announces FDA Clearance of IND for Phase 1/2 Trial of FasTCAR-T GC012F
27 Nov 2023 //
GLOBENEWSWIRE
Gracell to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit
16 Nov 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies Reports Third Quarter 2023 Unaudited Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies Wins Overall Immunology Solution of the Year
08 Nov 2023 //
GLOBENEWSWIRE
Gracell to Present Results from BCMA/CD19 Dual-Targeting FasTCAR-T GC012F
02 Nov 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
01 Nov 2023 //
GLOBENEWSWIRE
Gracell to Present Data Highlighting Efficacy of SMART CART Against Solid Tumors
31 Oct 2023 //
GLOBENEWSWIRE
Gracell to Report Third Quarter 2023 Financials on Monday, November 13, 2023
30 Oct 2023 //
GLOBENEWSWIRE
Gracell Doses First Patient in Phase 1b/2 Trial in U.S. Evaluating GC012F
26 Sep 2023 //
GLOBENEWSWIRE
Gracell CEO Dr. William Cao Named to Prestigious PharmaVoice 100
19 Sep 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences
14 Sep 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
24 Aug 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
CAR-T biotech throws 3 programs to the wind
14 Aug 2023 //
FIERCE BIOTECH
Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing
07 Aug 2023 //
PR NEWSWIRE
Gracell Biotechnologies to Participate in BTIG Virtual Biotechnology Conference
31 Jul 2023 //
GLOBENEWSWIRE
Gracell to Report Second Quarter 2023 Financials on Monday, August 14, 2023
31 Jul 2023 //
GLOBENEWSWIRE
Gracell to Participate in Truist Securities Cell Therapy Symposium
20 Jun 2023 //
GLOBENEWSWIRE
Why Shares of Gracell Biotechnologies Jumped Tuesday
13 Jun 2023 //
FOOL
Gracell Presents Data of Deep and Durable Responses for FasTCAR-T GC012F
03 Jun 2023 //
PRESS RELEASE
Gracell Biotechnologies to Participate in Jefferies Healthcare Conference
24 May 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F
15 May 2023 //
PR NEWSWIRE
Gracell Biotechnologies Reports1Q 2023 Unaudited FYR, Provides Corporate Update
15 May 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Host KOL Webinar on Multiple Myeloma on May 22nd
15 May 2023 //
GLOBENEWSWIRE
Gracell gives sneak peek into leukemia CAR-T cell program ahead of EHA
12 May 2023 //
ENDPTS
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
10 May 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Report 1Q 2023 Financials on Monday, May 15, 2023
02 May 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19
26 Apr 2023 //
PR NEWSWIRE
Gracell Biotechnologies Announces Filing of Its Annual Report on Form 20-F
25 Apr 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
22 Mar 2023 //
GLOBENEWSWIRE
Gracell Reports Fourth Quarter and Full Year 2022 Financial Results
13 Mar 2023 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
14 Feb 2023 //
GLOBENEWSWIRE
Gracell receives FDA clearance for multiple myeloma therapy trial
06 Feb 2023 //
CLINICAL TRIALS ARENA
Gracell Biotechnologies Reports 3Q 2022 Unaudited Financial Results
14 Nov 2022 //
GLOBENEWSWIRE
Gracell to Present Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma
03 Nov 2022 //
PRNEWSWIRE
Gracell Biotechnologies Reports Second Quarter 2022 Unaudited Financial Results
15 Aug 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies Appoints Wendy Li as CMO
01 Aug 2022 //
PRNEWSWIRE
Gracell Bio Appoints Veteran BioPharma Executive Dr. Samuel Zhang as CBO
19 Jul 2022 //
PRNEWSWIRE
Gracell Biotechnologies Reports First Quarter 2022 Unaudited Financial Results
16 May 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Three Investor Conferences in May
04 May 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies Announces Filing of Its Annual Report on Form 20-F
22 Apr 2022 //
GLOBENEWSWIRE
Gracell Biotechnologies to Participate in Three Investor Conferences in April
29 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio Reports Q4 and Full Year 2021 Unaudited Financial Results
14 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio to Participate in Oppenheimer 32nd Annual Healthcare Conference
10 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio to Report Q4 & Full Year 2021 Financial Results on March 14
02 Mar 2022 //
GLOBENEWSWIRE
Gracell Bio Announces Multiple Advancements of TruUCAR Allogeneic CAR-T Platform
22 Feb 2022 //
PRNEWSWIRE
Gracell Cell Therapy for Multiple Myeloma Granted FDA ODD
16 Jan 2022 //
TRIALSITENEWS
Gracell Biotech to open newly established Innovation Center in US
14 Jan 2022 //
PHARMABIZ
Gracell Biotechnologies Unveils Innovation Center in U.S.
12 Jan 2022 //
PRNEWSWIRE
Gracell Biotechnologies Announces Senior Management Team Share Purchase Plan
23 Nov 2021 //
PRNEWSWIRE
Gracell Granted FDA ODD to GC012F for Multiple Myeloma
19 Nov 2021 //
PRNEWSWIRE
Gracell Biotechnologies to Participate in Piper Sandler 33rd Annual VHC
17 Nov 2021 //
GLOBENEWSWIRE
Gracell Biotechnologies to Present Preclinical Results of TruUCAR- CD19/CD7
04 Nov 2021 //
PRNEWSWIRE
